$0.450
-0.034 (-7.61%)終値時点
NIVF のニュース
NIVF のイベント
NewGenIvf Group Files $100M Mixed Securities Shelf
NewGenIvf Group files $100M mixed securities shelf
NewGenIvf Group Ltd Trading Halted, News Pending
NewGenIvf Group Ltd trading halted, news pending
NewGenIvf Group Ltd Trading Halted, News Pending
NewGenIvf Group Ltd trading halted, news pending
NewGenIvf Group Prices Public Offering at $1.25M
NewGenIvf Group announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the company expected to be approximately $1.25M, before deducting placement agent fees and other offering expenses payable by the company. The offering consists of 17,857,143 Ordinary Shares or Pre-Funded Warrants in lieu thereof. The public offering price per Common Share is 7c, or 6.999c for each Pre-Funded Warrant, which is equal to the public offering price per Ordinary Share to be sold in the offering minus an exercise price of $0.00001 per Pre-Funded Warrant. Aggregate gross proceeds to the company are expected to be approximately $1.25M. The transaction is expected to close on or about September 30, 2026, subject to the satisfaction of customary closing conditions. Aegis Capital Corp. is acting as the exclusive placement agent for the offering.
NewGenIvf Group Ltd Trading Halted, News Pending
NewGenIvf Group Ltd trading halted, news pending
関連記事
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。




